Welcome to LookChem.com Sign In|Join Free

CAS

  • or

114870-02-9

Post Buying Request

114870-02-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • α-D-Glucopyranoside, methyl O-2-amino-2-deoxy-6-O-sulfo-α-D-glucopyranosyl-(1→4)-O-β-D-glucopyranuronosyl-(1→4)-O-2-amino-2-deoxy-3,6-di-O-sulfo-α-D-glucopyranosyl-(1→4)-O-2-O-sulfo-α-L-idopyr

    Cas No: 114870-02-9

  • No Data

  • No Data

  • 10000 Metric Ton/Month

  • Henan Wentao Chemical Product Co., Ltd.
  • Contact Supplier
  • α-D-Glucopyranoside, methyl O-2-amino-2-deoxy-6-O-sulfo-α-D-glucopyranosyl-(1→4)-O-β-D-glucopyranuronosyl-(1→4)-O-2-amino-2-deoxy-3,6-di-O-sulfo-α-D-glucopyranosyl-(1→4)-O-2-O-sulfo-α-L-idopyr

    Cas No: 114870-02-9

  • No Data

  • No Data

  • No Data

  • Dragonfarm
  • Contact Supplier

114870-02-9 Usage

General Description

Fondaparinux sodium Intermediate A is a chemical compound that is used in the synthesis of the anticoagulant drug fondaparinux sodium. It serves as an important intermediate in the production process, facilitating the conversion of precursor compounds into the final active pharmaceutical ingredient. Fondaparinux sodium is widely used for the prevention and treatment of deep vein thrombosis and pulmonary embolism, and this intermediate plays a crucial role in its manufacturing process. It is a key component in the pharmaceutical industry, contributing to the production of an important medication that helps to reduce the risk of blood clotting and associated complications.

Check Digit Verification of cas no

The CAS Registry Mumber 114870-02-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,4,8,7 and 0 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 114870-02:
(8*1)+(7*1)+(6*4)+(5*8)+(4*7)+(3*0)+(2*0)+(1*2)=109
109 % 10 = 9
So 114870-02-9 is a valid CAS Registry Number.

114870-02-9Upstream product

114870-02-9Downstream Products

114870-02-9Relevant articles and documents

Programmable One-Pot Synthesis of Heparin Pentasaccharide Fondaparinux

Dey, Supriya,Lo, Hong-Jay,Wong, Chi-Huey

, (2020)

The clinically approved Fondaparinux (Arixtra) has been used for the treatment of deep vein thrombosis and acute pulmonary embolism since 2002 and is considered to be better than the low-molecular weight heparin in terms of anticoagulation response, duration of action, and biosafety. However, the synthetic methods previously developed for its manufacture are relatively complicated, thus restricting its extensive use. We report here a potentially scalable and programmable one-pot synthesis of Fondaparinux using the [1,2,2] strategy and designed thioglycosides with well-defined reactivity as building blocks.

PROCESS FOR THE PRODUCTION OF FONDAPARINUX SODIUM

-

Paragraph 0132-0134, (2017/02/24)

The present invention refers to a fly step compounds of formula ABC5 novel sodium [...] provides manufacturing method: In some embodiments, step for the synthesis intermediates are sodium [...] fly is provided in addition. (by machine translation)

PROCESS FOR THE PRODUCTION OF FONDAPARINUX SODIUM

-

Paragraph 0066; 0067, (2015/02/19)

The present invention provides improved processes of preparing Fondaparinux sodium comprising converting a compound of formula ABCDE4 to Fondaparinux sodium at a reaction pH of no more than about 9.0. In some embodiments, the intermediates for the synthes

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 114870-02-9